Modern Healthcare Technology Issues FY2025/26 ESG Report – Scope-2 Emissions Fall 12.5%, Water Use Down 16.9%, New Targets Set for FY2026/27

Bulletin Express
07/27

Modern Healthcare Technology released its Environmental, Social and Governance (ESG) Report for the year ended 31 March 2026, covering 46 “be Beauty Shop” points of sale and service centres in Hong Kong and Singapore.

The report shows a 9.50% year-on-year reduction in total greenhouse-gas (GHG) emissions to 1,784.68 tonnes of CO₂-equivalent. Scope-2 (energy-indirect) emissions, which account for 94.93% of the Group’s total, dropped 12.50% to 1,694.12 tonnes, while Scope-1 (direct) emissions rose to 80.41 tonnes after the inclusion of refrigerant leakage data. Scope-3 (other indirect) emissions were broadly unchanged at 10.15 tonnes.

Electricity consumption was largely flat at 3.54 million kWh (+0.60%), but overall energy use edged up 0.90% to 3.64 million kWh after higher diesel demand. Water consumption declined 16.90% to 17,941.91 m³, and non-hazardous packaging waste fell to 14.46 tonnes from 17.04 tonnes.

Operational targets for FY2026/27 are to keep the intensity of air emissions, GHG emissions, town-gas use, electricity use, water consumption, wastewater discharge and non-hazardous waste at FY2025/26 levels. The Group also aims to switch 50% of its packaging to recycled paper by 2030.

Governance of ESG matters rests with the Board, which integrates the United Nations Sustainable Development Goals into strategy. Material focus areas are employee management, product responsibility, and business ethics and compliance. Supply-chain oversight covers 125 suppliers—45 in Hong Kong, 68 in mainland China and 12 elsewhere—with 100% subject to the Group’s engagement and assessment procedures.

Climate-related disclosures have been expanded in line with IFRS S2. Key physical and transition risks include extreme weather and tightening regulations; opportunities cited involve growing demand for sustainable products and lower long-term energy costs. Quantitative scenario analysis and Scope-3 expansion are in development.

Social indicators show a workforce of 780 employees, turnover of 21.5%, zero fatalities, four work-related injuries (444 lost days) and 18,369.5 training hours delivered to 611 employees. No product recalls, privacy breaches or concluded corruption cases were reported during the year, and the Group maintained compliance with all relevant environmental and labour regulations.

Management reiterates that ESG considerations are embedded in decision-making processes to support sustainable growth across its health and beauty operations.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10